Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.060 -0.020 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
December 22, 2015
Form S-8
Source: SEC/Edgar
December 13, 2015
Form 8-K
Source: SEC/Edgar
December 13, 2015
Form SC 13G
Source: SEC/Edgar
December 06, 2015
Form 8-K
Source: SEC/Edgar
November 08, 2015
Form 424B5
Source: SEC/Edgar
November 03, 2015
Form 8-K
Source: SEC/Edgar
November 03, 2015
Form 8-K
Source: SEC/Edgar
November 01, 2015
Form 424B5
Source: SEC/Edgar
November 01, 2015
Form EFFECT
Source: SEC/Edgar
November 01, 2015
Form 8-K
Source: SEC/Edgar
October 28, 2015
Form S-3
Source: SEC/Edgar
October 15, 2015
Form 8-K
Source: SEC/Edgar
August 05, 2015
Form 8-K
Source: SEC/Edgar
July 01, 2015
Form CT ORDER
Source: SEC/Edgar
June 08, 2015
Form 8-K
Source: SEC/Edgar
June 02, 2015
Form 8-K
Source: SEC/Edgar
May 12, 2015
Form 8-K
Source: SEC/Edgar
May 12, 2015
Form 8-K
Source: SEC/Edgar
May 03, 2015
Form S-8
Source: SEC/Edgar
April 02, 2015
Form ARS
Source: SEC/Edgar
March 29, 2015
Form DEF 14A
Source: SEC/Edgar
March 25, 2015
Form 424B5
Source: SEC/Edgar
March 18, 2015
Form EFFECT
Source: SEC/Edgar
March 17, 2015
Form S-3
Source: SEC/Edgar
March 03, 2015
Form 8-K
Source: SEC/Edgar
March 01, 2015
Form 8-K
Source: SEC/Edgar
February 26, 2015
Form SC 13G
Source: SEC/Edgar
February 16, 2015
Form SC 13G/A
Source: SEC/Edgar
February 12, 2015
Form 8-K
Source: SEC/Edgar
February 02, 2015
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.